CNS & Neurological Disorders - Drug Targets

Formerly Current Drug Targets - CNS & Neurological Disorders


Edoardo Spina
Department of Clinical and Experimental Medicine
University of Messina
Policlinico Universitario
Via Consolare Valeria

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 8 Issue: 1, March

Editorial [Hot Topic:Active and Passive Aβ-Immunotherapy: Preclinical and Clinical Studies and Future Directions: Part I (Guest Editors: Michael G. Agadjanyan and David H. Cribbs)]

Volume:8   Issue: 1
Pp: 1-6
Michael G. Agadjanyan and David H. Cribbs
DOI: 10.2174/187152709787601849
Published on: 01 March, 2012

The Role of Microglia in Antibody-Mediated Clearance of Amyloid-Beta from the Brain

Volume:8   Issue: 1
Pp: 7-15
Dave Morgan
DOI: 10.2174/187152709787601821
Published on: 01 March, 2012

Clearance of Amyloid-β Peptide Across the Blood-Brain Barrier: Implication for Therapies in Alzheimers Disease

Volume:8   Issue: 1
Pp: 16-30
R. Deane, R. D. Bell, A. Sagare and B. V. Zlokovic
DOI: 10.2174/187152709787601867
Published on: 01 March, 2012

Quantitative and Mechanistic Studies of Aβ Immunotherapy

Volume:8   Issue: 1
Pp: 31-49
Todd E. Golde, Pritam Das and Yona Levites
DOI: 10.2174/187152709787601830
Published on: 01 March, 2012

Immunotherapy, Vascular Pathology, and Microhemorrhages in Transgenic Mice

Volume:8   Issue: 1
Pp: 50-64
Donna M. Wilcock and Carol A. Colton
DOI: 10.2174/187152709787601858
Published on: 01 March, 2012

Targeting Generation of Antibodies Specific to Conformational Epitopes of Amyloid β-Derived Neurotoxins

Volume:8   Issue: 1
Pp: 65-81
Mary P. Lambert, Pauline T. Velasco, Kirsten L. Viola and William L. Klein
DOI: 10.2174/187152709787601876
Published on: 01 March, 2012